Teenage girls who compulsively text are more likely than their male counterparts to do worse academically, according to research published by the American Psychological Association.
First introduced in the United States in 2007, electronic cigarettes have risen dramatically in part because they are popularly considered safer and more socially acceptable than combustible cigarettes and because there are fewer restrictions on their purchase and use. A study by University of California, San Diego School of Medicine researchers, published in the journal Drug and Alcohol Dependence, points to aggressive online marketing tactics that make purchasing e-cigarettes easy for all ages.
Two decades after a UCSF researcher proposed that reducing nicotine in cigarettes as a national regulatory policy might facilitate quitting, a new study he co-authored has added to a body of evidence that indicates that doing just that may accomplish this goal.
Wayne State University has been awarded a three-year, $945,000 grant from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) to train 100 undergraduate and graduate students each year in Screening, Brief Intervention, and Referral to Treatment (SBIRT).
A new study from The Scripps Research Institute has shown that a specific molecule controls morphine receptor signaling in a small group of brain cells. The findings could lead to a new drug target for developing less-addictive pain medications.
Following substance abuse treatment, individuals who live in a collaborative housing setting with community rules and responsibilities have their substance abuse treated more effectively than those not provided supportive housing, according to research led by Leonard Jason, a community psychologist at DePaul University.
A study of Internet pornography users suggests a person’s own feeling of being addicted to online pornography drives mental health distress, not the pornography itself. Researcher Joshua Grubbs, a doctoral candidate at Case Western Reserve University’s Department of Psychological Sciences, said the finding adds a fresh perspective to commonly held concerns that Internet pornography can be a threat to mental health. The research, funded by the John Templeton Foundation, suggests that feeling addicted to Internet pornography is associated with depression, anger, and anxiety, but that actual use of pornography is not.
You’ve tried to escape it. You really have. But, the constant stream of dings and buzzes from incoming texts and emails are just too much to take. And, before you know it, you’re scanning your smartphone. Again. Can the cycle be broken? Can people really put down their smartphones?
New research at Washington University School of Medicine in St. Louis may help explain why drug treatments for addiction and depression don’t work for some patients. The conditions are linked to reward and aversion responses in the brain. And the research suggests that some treatments simultaneously stimulate reward and aversion responses, resulting in a net zero effect.
Expert can discuss the need to address the issue of heroin and prescription opioid abuse by developing innovative medical treatments. Specifically, he can describe the features and benefits of an inside-the-cheek format of buprenorphine for the maintenance treatment of opioid addiction.
Heroin use has increased 63 percent over the last 10 years according to (CDC). That increase, according to the agency, is closely tied to the growing abuse of prescription opioids such as oxycodone (Percocet), hydrocodone (Vicodin) and codeine. An alarming 45 percent of Americans addicted to heroin are also addicted to prescription opioids.
The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine.
One of the most commonly used treatment models in addiction is the 12-step model developed in the 1930s and rooted in spirituality. Yet, surprisingly, there is no clear understanding about how to nurture spirituality among people struggling with addictions.
Alcoholism inflicts a heavy physical, emotional and financial toll on individuals and society. Now new discoveries and promising animal studies are offering a glimmer of hope that a new class of drugs could treat the disease without many of the unwanted side effects caused by current therapies. The scientists are presenting their work today at the 250th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society.
Children and adolescents who receive integrated mental health and medical treatment are 66 percent more likely to have a good outcome than those who receive more traditional primary care.
A study from scientists at The Scripps Research Institute explores a bacterial enzyme that might be used as a drug candidate to help people quit smoking. The research shows this enzyme can be recreated in lab settings and possesses a number of promising characteristics for drug development.
Despite the growing use of online support groups such as those on Facebook to help curb substance abuse, attending traditional face-to-face meetings may continue to be more effective for people trying to maintain sobriety, according to research presented at the American Psychological Association’s 123rd Annual Convention.
Scientists from the Florida campus of The Scripps Research Institute have made a discovery that brings them closer to a new therapy based on selectively erasing dangerous and tenacious drug-associated memories.
The research seeks to identify the potential role of drug use in increasing risk of sexual violence among young adult opioid users in NYC, and to identify the specific social and contextual factors surrounding this group’s experiences of sexual violence.
Researchers at McGill University have clearly identified, for the first time, the specific parts of the brain involved in decisions that call for delayed gratification. They demonstrated that the hippocampus (associated with memory) and the nucleus accumbens (associated with pleasure) work together in making critical decisions of this type, where time plays a role.
Abstinence is the best way to avoid drug addiction. But in many societies, drug use is the norm, not the exception, especially by youth. What keeps the majority of users from becoming addicted? How drugs are taken has something to do with it, according to pharmacology researchers at the University of Montreal.
During National Chiropractic Health Month (NCHM) in October, the American Chiropractic Association (ACA) will work with thousands of doctors of chiropractic (DCs), chiropractic assistants (CAs) and chiropractic doctoral students nationwide to bring attention to the public health crisis caused by pain, and in particular the overuse of prescription painkillers, with this year’s theme #PainFreeNation.
Ortho-Clinical Diagnostics, Inc. (OCD) today announced the presentation of data for five assays under development. The assays address a range of important tests for clinical labs including HIV, acute kidney injury and cardiac troponin I. The scientific posters will be delivered during the 2015 American Association for Clinical Chemistry Annual Meeting to be held July 26 - 30 in Atlanta, Georgia.
The Lee Company’s new Hard Seat VHS Micro-Dispense Valve features the speed and reliability of Lee’s traditional VHS valves, but the traditional elastomeric seal has been replaced with a precision zirconia ball and seat. The result is a valve offering precise, repeatable, non-contact dispensing in the nanoliter to microliter range which is well suited for DMSO and other fluids that typically react with elastomeric seals.
A new University of Michigan study finds that teens using marijuana for medical reasons are 10 times more likely to say they are hooked on marijuana than youth who get marijuana illegally.
The Lee Company's new atomizing nozzles, available in both airless and air assisted styles, generate a 50° hollow cone spray pattern and offer precise, controlled atomization in a compact package.
The Double Ended Piston Pumps of Diener Precision Pumps allow up to two different liquids and two different flow or stroke volume displacement rates in one application. The pumps have a space and economical saving design. Diener Precision Pumps is the Swiss Quality pump and valve manufacturer specialized in customer tailored solutions.
The quality manufacturer of piston pumps and gear pumps Diener Precision Pumps, founded in 1994, was recertified according to the medical standards ISO 9001/ ISO 13485. On the company website, users are newly provided with a chart helping application engineers to evaluate the compatibility of different chemical substances.
UTAK Laboratories announces the release of their SMx™ (Specialty Matrix) Product Line. UTAK’s SMx™ Matrices replicate some of the most challenging Laboratory Testing Methodologies and have performed in real-life Laboratory conditions to a standard that is uniquely reserved for UTAK products.
Streck will be a sponsor and exhibitor at the AACC Annual Meeting & Clinical Lab Expo. Streck has a number of new products this year; find us at booth #2552 to learn more
Visiun, Inc., the leader in performance analytics for the laboratory, is celebrating 5 years of proudly supporting the laboratory community and will be showcasing their feature-rich Performance Insight™ at the AACC Clinical Lab Expo, taking place July 28-30, at the Georgia World Congress Center in Atlanta, Georgia
— Visiun, Inc., the leader in performance analytics for the laboratory, announced today that the Compass Group has awarded them a sole source agreement for business intelligence software for their 26 health systems, encompassing over 380 hospitals nationwide. Following a vendor evaluation process, the Compass Group selected Visiun’s feature-rich Performance Insight™.
Parker Hannifin Corporation announces the release of the R9 Diaphragm Rocker Isolation Liquid Valve, a family of 9 mm valves that improves performance of Clinical Diagnostic, Analytical Chemistry and Agent Detection systems requiring precision fluid control
Enigma Diagnostics Ltd. (Enigma) and Beijing Leadman Biochemistry Co., Ltd. (Beijing Leadman) (SZSE:300289) signed a joint venture agreement with the principal goal of delivering the Enigma MiniLab molecular diagnostic Point-of-Care platform into the Chinese health care market to support its growing diagnostic needs.
The BBI Group (BBI) today announced it has developed in collaboration with the Defence Science and Technology Laboratory (Dstl) and licensed, through technology transfer company Ploughshare Innovations, a rapid test for Ebola. The assay, which is in the process of being verified to allow EUA submission, will be used to test patients suspected of Ebola infection to screen and potentially help with how they are subsequently managed. The test, utilising lateral flow technology, can provide a result in approximately 20 minutes.
As BBI Solutions (BBI) prepare for its 25th consecutive attendance at AACC, visitors to the BBI booth can expect to discover the increasing importance of high quality biological raw materials in driving assay performance and how BBI’s new, innovative products can help achieve this.
Today Siemens Healthcare Diagnostics reveals its latest in vitro diagnostic solu-tions—including the recently FDA-cleared ADVIA Centaur XPT Immunoassay Sys-tem1—at the 2015 AACC Annual Meeting and Clinical Lab Expo, Atlanta, July 26–30. In addition to featuring its portfolio of multidisciplinary solutions designed for use in hospital, reference, and physician office laboratories and near patients’ bedsides, the booth will highlight how Siemens’ customers around the world are achieving their clinical and workflow goals.
Over 70 world renowned experts in the field of antimicrobial resistance met in Annecy for the 5th edition of the World HAI/Resistance Forum, sponsored by bioMérieux, a world leader in the field of in vitro diagnostics and leader in microbiology. The Forum provided the opportunity to share their global experience and expertise in antimicrobial resistance in humans, animals, the environment and food. The discussions confirmed the need to create synergies between these different sectors. As resistance impacts both people and animals, coordinated action between human and veterinary medicine is essential to effectively combat this global public health threat. The experts also underlined the need for education of healthcare professionals as well as other user targets. They proposed a series of concrete, innovative educational actions, and selected as a priority the development of an international project, which bioMérieux committed to support.
bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the introduction of its new FDA-cleared tests to rapidly detect Lyme Disease in just 27 minutes.
bioMérieux, a world leader in the field of in vitro diagnostics, launches My Role Matters (#MyRoleMatters). This is a new campaign which calls upon all United States healthcare, animal, pharmaceutical and product safety professionals, government officials and the community at large to understand the impact their role can play in halting the increase and spread of antimicrobial resistant pathogens and promoting appropriate antimicrobial use.
UTAK Laboratories, Inc., dedicated to meeting the quality control needs of laboratories worldwide, proudly announced today the release of the Expanded Steroid Control manufactured with UTAK’s proprietary SMx™ Serum Specialty Matrix.
bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, received FDA 510(k) clearance. This instrument, which further enriches the offering of the VIDAS® immunoassay product range, VIDAS® and mini VIDAS®, is now commercially available in the United States. VIDAS® 3 is CE marked and registered at the Chinese Food and Drug Administration (CFDA) which makes it available to clinical labs on a global scale.
New technology from product design and development firm Cambridge Consultants is set to bring radical innovation to the diagnostics market. Ingenious use of inkjet printing techniques has made it possible to create a diagnostic test cartridge from a single sheet of paper. The breakthrough paves the way for sophisticated low-cost tests that can be adapted at the touch of a button – and printed in quantities ranging from one to millions.
bioMérieux, a world leader in the field of in vitro diagnostics, has been invited to join the White House Forum on Antibiotic Stewardship for the improvement of antibiotic use in the U.S. as a means to address antibiotic resistance. Over 150 major experts from various sectors, will gather tomorrow, June 2, 2015, to discuss the possible ways to implement changes over the next five years to slow the emergence of antibiotic-resistant bacteria, and prevent the spread of resistant infections and preserve the efficacy of our existing antibiotics.
Beckman Coulter will be showing the Aquios CL Flow Cytometer and setting up one-to-one demonstrations at their Booth #521 during the 2015 AACC Annual Meeting & Clinical Lab Expo to be held in Atlanta, Georgia, July 28-30, 2015.
MedCompGx, a division of MedComp Sciences based in Memphis, Tennessee, today announced the installation and implementation of UNIConnect’s Precision MDx (pMDxtm) laboratory information management system (LIMS) for its new genetic testing lab. The system is designed to provide comprehensive automation of all laboratory processes, while integrating with multiple systems under one umbrella. The installation of pMDx will help to advance MedCompGx’s mission to promote innovation in healthcare that creates better outcomes for patients by promoting healthy lifestyles through personalized medicine.